Exelon (NASDAQ:EXC – Get Rating) had its price target upped by equities research analysts at KeyCorp from $51.00 to $53.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. KeyCorp’s price objective indicates a potential upside of 7.07% from the company’s current price.
A number of other equities analysts also recently commented on EXC. The Goldman Sachs Group downgraded shares of Exelon from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $62.00 to $44.00 in a research note on Friday, February 4th. Zacks Investment Research upgraded Exelon from a “sell” rating to a “hold” rating and set a $53.00 price objective for the company in a research report on Tuesday, April 12th. Barclays started coverage on Exelon in a research report on Monday, February 7th. They issued an “equal weight” rating and a $46.00 target price on the stock. JPMorgan Chase & Co. raised Exelon from a “neutral” rating to an “overweight” rating and upped their price target for the company from $47.00 to $55.00 in a research note on Wednesday. Finally, Mizuho raised Exelon from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $43.00 to $46.00 in a research report on Friday, March 11th. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $47.83.
Shares of EXC stock opened at $49.50 on Wednesday. The company has a current ratio of 0.87, a quick ratio of 0.75 and a debt-to-equity ratio of 1.03. Exelon has a twelve month low of $30.57 and a twelve month high of $50.29. The company’s 50-day moving average price is $44.77 and its 200-day moving average price is $50.23. The stock has a market cap of $48.52 billion, a price-to-earnings ratio of 28.45, a PEG ratio of 3.49 and a beta of 0.59.
A number of institutional investors have recently modified their holdings of EXC. Fifth Third Bancorp grew its stake in shares of Exelon by 5.8% during the first quarter. Fifth Third Bancorp now owns 242,407 shares of the company’s stock worth $11,546,000 after purchasing an additional 13,320 shares in the last quarter. AE Wealth Management LLC raised its position in shares of Exelon by 35.7% during the 1st quarter. AE Wealth Management LLC now owns 153,981 shares of the company’s stock worth $7,334,000 after acquiring an additional 40,532 shares in the last quarter. IFM Investors Pty Ltd lifted its stake in Exelon by 19.7% during the first quarter. IFM Investors Pty Ltd now owns 153,536 shares of the company’s stock worth $7,313,000 after purchasing an additional 25,284 shares during the last quarter. Wealthcare Advisory Partners LLC boosted its holdings in Exelon by 1.7% in the first quarter. Wealthcare Advisory Partners LLC now owns 16,808 shares of the company’s stock valued at $801,000 after purchasing an additional 288 shares in the last quarter. Finally, Steph & Co. increased its stake in Exelon by 5.4% in the first quarter. Steph & Co. now owns 12,512 shares of the company’s stock valued at $596,000 after purchasing an additional 639 shares during the last quarter. Institutional investors own 79.73% of the company’s stock.
Exelon Company Profile (Get Rating)
Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.
- Get a free copy of the StockNews.com research report on Exelon (EXC)
- Is Turning Point Therapeutics Stock at a Turning Point?
- Buy Haliburton On Post-Earnings Weakness
- Constellation Brands Stock is Launching Towards New Highs
- 3 Analyst Favorite Blue-Chip Stocks to Buy Now
- Does PNC Financial Stock Belong in Your Portfolio?
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.